Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients

被引:82
作者
Chitalia, Nihil
Recio-Mayoral, Alejandro
Kaski, Juan Carlos
Banerjee, Debasish [1 ]
机构
[1] Univ London, Renal & Transplantat Unit, St Georges Healthcare NHS Trust, London SW17 0QT, England
关键词
Vitamin D; Chronic kidney disease; Endothelial dysfunction; CORONARY-ARTERY-DISEASE; STAGE RENAL-DISEASE; CHRONIC-HEMODIALYSIS PATIENTS; CARDIOVASCULAR OUTCOMES; MINERAL METABOLISM; INFLAMMATION; MORTALITY; CELLS; DIMETHYLARGININE; ATHEROSCLEROSIS;
D O I
10.1016/j.atherosclerosis.2011.10.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular (CV) events are common in patients with chronic kidney disease (CKD) but inadequately explained by traditional risk factors. Vitamin D deficiency is highly prevalent in CKD and has been proposed to be a non-traditional risk factor, but its relationship with vascular function is unknown. Methods and results: The aim of this study was to investigate the relationship between vitamin D levels and endothelial function in non-diabetes patients with mild to moderate CKD. Endothelial function was measured non-invasively using brachial artery flow mediated dilation (FMD). 25 hydroxy vitamin D levels were measured using electrochemiluminescence immunoassay. In 50 CKD patients (age 56 +/- 11 years, BMI 25 +/- 4 kg/m(2), 46% females, 14% smokers, 86% hypertensives, 52% with dyslipidaemia) the mean vitamin D level was 53 +/- 33 nmol/L (21 +/- 13 ng/L). The mean FMD was 3.8 +/- 2.4%. Decreasing 25 hydroxy vitamin D levels were associated with decreasing FMD [r = 0.44, p = 0.001]. In multivariate analysis the association remained independent after adjustment with traditional risk factors (adjusted beta 0.451; t = 3.46; p < 0.002). Patients with low vitamin D (<= 37.5 nmol/L) demonstrated low FMD compared to patients with vitamin D values > 37.5 nmol/L (4.4 +/- 2.5% vs. 2.5 +/- 1.6%; p = 0.007); however the traditional risk factors were similar between the two groups. Conclusion: This is the first demonstration of an association of vitamin D deficiency with abnormal vascular endothelial function in non-dialysis CKD patients. Further studies with intervention and exploration of the mechanism are needed to establish a cause effect relationship. Crown Copyright (C) 2011 Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 33 条
[1]   Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis [J].
Ambrus, Cs. ;
Almasi, Cs. ;
Berta, K. ;
Deak, Gy. ;
Marton, A. ;
Molnar, M. Zs. ;
Nemeth, Zs. ;
Horvath, Cs. ;
Lakatos, P. ;
Szathmari, M. ;
Mucsi, I. .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (02) :475-482
[2]  
Becker BN, 1997, J AM SOC NEPHROL, V8, P475
[3]   Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein [J].
Beckman, JA ;
Liao, JK ;
Hurley, S ;
Garrett, LA ;
Chui, DS ;
Mitra, D ;
Creager, MA .
CIRCULATION RESEARCH, 2004, 95 (02) :217-223
[4]   Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals [J].
Bodyak, Natalya ;
Ayus, Juan Carlos ;
Achinger, Steven ;
Shivalingappa, Venkatesha ;
Ke, Qingen ;
Chen, Yee-Shiuan ;
Rigor, Debra L. ;
Stillman, Isaac ;
Tamez, Hector ;
Kroeger, Paul E. ;
Wu-Wong, Ruth R. ;
Karumanchi, S. Ananth ;
Thadhani, Ravi ;
Kang, Peter M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (43) :16810-16815
[5]   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[6]   Vitamin D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis [J].
Elamin, Mohamed B. ;
Abu Elnour, Nisrin O. ;
Elamin, Khalid B. ;
Fatourechi, Mitra M. ;
Alkatib, Aziz A. ;
Almandoz, Jaime P. ;
Liu, Hau ;
Lane, Melanie A. ;
Mullan, Rebecca J. ;
Hazem, Ahmad ;
Erwin, Patricia J. ;
Hensrud, Donald D. ;
Murad, Mohammad Hassan ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (07) :1931-1942
[7]   Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension [J].
Ghiadoni, L ;
Virdis, A ;
Magagna, A ;
Taddei, S ;
Salvetti, A .
HYPERTENSION, 2000, 35 (01) :501-506
[8]   Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease [J].
Gokce, N ;
Keaney, JF ;
Hunter, LM ;
Watkins, MT ;
Nedeljkovic, ZS ;
Menzoian, JO ;
Vita, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1769-1775
[9]   Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease [J].
Heitzer, T ;
Schlinzig, T ;
Krohn, K ;
Meinertz, T ;
Münzel, T .
CIRCULATION, 2001, 104 (22) :2673-2678
[10]  
Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI [10.1210/jc.2011-0385, 10.1210/jc.2011-1193]